Literature DB >> 34488593

Recent Advances in the Development of Pyrazolopyridines as Anticancer Agents.

Xiaotong Gu1, Shutao Ma1.   

Abstract

Cancer, especially malignant tumor, is a serious threat to people's life and health. It is recognized as an enormous challenge in the 21st century. Continuous efforts are needed to overcome this problem. Pyrazolopyridine nucleus, similar in structure to purine, shows a variety of biological activities, which is mainly attributed to the antagonistic nature towards the natural purines in many biological processes. This has aroused enormous attention for many researchers. At present, a large number of new chemical entities containing pyrazolopyridine nucleus have been found as anticancer agents. In this review we summarize novel pyrazolopyridine-containing derivatives with biological activities. Furthermore, we outline the relationships between the structures of variously modified pyrazolopyridines and their anticancer activity. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; anticancer agents; biological activity; heterocyclic compounds; pyrazolopyridines; structures-activity relationship

Mesh:

Substances:

Year:  2022        PMID: 34488593     DOI: 10.2174/1871520621666210901102832

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.527


  1 in total

1.  Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies.

Authors:  Andrea Angeli; Victor Kartsev; Anthi Petrou; Boris Lichitsky; Andrey Komogortsev; Mariana Pinteala; Athina Geronikaki; Claudiu T Supuran
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.